Market Overview

DA Davidson Downgrade Pushes Clearwater Paper Shares Down 2%

Share:

Shares of Clearwater Paper Corp (NYSE: CLW) fell below the $60 level Thursday following an intraday downgrade from DA Davidson analyst Steven Chercover.

The analyst set a Neutral rating on the stock, down from a prior Buy rating. Chercover has a $65 12-18 month price target on Clearwater shares, and an $85 five-year price target.

The lowered investment recommendation came on the heels of outperformance by the stock against its Paper & Packaging peers, "appreciating ~35%, and have almost doubled since reaching a 52-week low ($32) reached during what we like to call 'the point of maximum pessimism' back in mid-February," Chercover said.

Notably, and despite the Neutral rating, Chercover suggested investors should "be nimble in the event of a pullback."

Clearwater Paper shares closed down nearly 2.3 percent at $59.99 Thursday.

Latest Ratings for CLW

DateFirmActionFromTo
Aug 2019DowngradesSector PerformUnderperform
Aug 2018DowngradesOutperformSector Perform
May 2018UpgradesSector PerformOutperform

View More Analyst Ratings for CLW
View the Latest Analyst Ratings

Posted-In: DA Davidson Steven ChercoverAnalyst Color News Downgrades Price Target Analyst Ratings Movers

 

Related Articles (CLW)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ARMKBarclaysMaintains45.0
HDDZ BankDowngrades
COGWolfe ResearchUpgrades
MLHRSidoti & Co.Maintains45.0
ICFISidoti & Co.Maintains99.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold

Howard Lindzon AMA: Start Investing, Study Behavior, Follow The Right People